Literature DB >> 27766568

ADPKD: clinical issues before and after renal transplantation.

Piergiorgio Messa1,2, Carlo Maria Alfieri3,4, Emanuele Montanari3,5, Mariano Ferraresso3,6, Roberta Cerutti3,4.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the first genetic cause of end-stage renal disease (ESRD) and the number of these patients who are listed for or receive a kidney transplant (KTx) is continuously increasing over time. Hence, nephrologists are involved not only in the handling of ADPKD patients during the long course of the disease, but also in programming and performing a renal transplant. The handling of all these processes implies the complete awareness of a number of critical points related to the decisions to be taken both before and after the transplant intervention. In the present review, we will briefly deal with the main critical points related to the clinical handling of the patients both before and after KTx.

Entities:  

Mesh:

Year:  2016        PMID: 27766568     DOI: 10.1007/s40620-016-0349-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  90 in total

1.  Native nephrectomy in transplant patients with autosomal dominant polycystic kidney disease.

Authors:  P Patel; C Horsfield; F Compton; J Taylor; G Koffman; J Olsburgh
Journal:  Ann R Coll Surg Engl       Date:  2011-07       Impact factor: 1.891

2.  Embolization of renal arteries before transplantation in patients with polycystic kidney disease: a single institution long-term experience.

Authors:  F Petitpierre; F Cornelis; L Couzi; A S Lasserre; E Tricaud; Y Le Bras; P Merville; C Combe; J M Ferriere; N Grenier
Journal:  Eur Radiol       Date:  2015-05-17       Impact factor: 5.315

Review 3.  Cystic disease in women: clinical characteristics and medical management.

Authors:  Arlene B Chapman
Journal:  Adv Ren Replace Ther       Date:  2003-01

4.  One hundred consecutive kidney transplantations with simultaneous ipsilateral nephrectomy in patients with autosomal dominant polycystic kidney disease.

Authors:  Hannes Philipp Neeff; Przemyslaw Pisarski; Dietlind Tittelbach-Helmrich; Konstantin Karajanev; Hartmut P H Neumann; Ulrich Theodor Hopt; Oliver Drognitz
Journal:  Nephrol Dial Transplant       Date:  2012-10-04       Impact factor: 5.992

5.  Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Authors:  Loes van Keimpema; Frederik Nevens; Ragna Vanslembrouck; Martijn G H van Oijen; Aswin L Hoffmann; Helena M Dekker; Robert A de Man; Joost P H Drenth
Journal:  Gastroenterology       Date:  2009-07-29       Impact factor: 22.682

6.  Unified criteria for ultrasonographic diagnosis of ADPKD.

Authors:  York Pei; James Obaji; Annie Dupuis; Andrew D Paterson; Riccardo Magistroni; Elizabeth Dicks; Patrick Parfrey; Benvon Cramer; Eliecer Coto; Roser Torra; Jose L San Millan; Robert Gibson; Martijn Breuning; Dorien Peters; David Ravine
Journal:  J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 10.121

7.  Kidney and liver transplantation in children with fibrocystic liver-kidney disease: data from the US Scientific Registry of Transplant Recipients: 1990-2010.

Authors:  Jessica W Wen; Susan L Furth; Rebecca L Ruebner
Journal:  Pediatr Transplant       Date:  2014-07-29

8.  Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial.

Authors:  Anna Caroli; Norberto Perico; Annalisa Perna; Luca Antiga; Paolo Brambilla; Antonio Pisani; Bianca Visciano; Massimo Imbriaco; Piergiorgio Messa; Roberta Cerutti; Mauro Dugo; Luca Cancian; Erasmo Buongiorno; Antonio De Pascalis; Flavio Gaspari; Fabiola Carrara; Nadia Rubis; Silvia Prandini; Andrea Remuzzi; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Lancet       Date:  2013-08-21       Impact factor: 79.321

9.  Measuring and estimating GFR and treatment effect in ADPKD patients: results and implications of a longitudinal cohort study.

Authors:  Piero Ruggenenti; Flavio Gaspari; Antonio Cannata; Fabiola Carrara; Claudia Cella; Silvia Ferrari; Nadia Stucchi; Silvia Prandini; Bogdan Ene-Iordache; Olimpia Diadei; Norberto Perico; Patrizia Ondei; Antonio Pisani; Erasmo Buongiorno; Piergiorgio Messa; Mauro Dugo; Giuseppe Remuzzi
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

Review 10.  Laparoscopic Nephrectomy versus Open Nephrectomy for Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis.

Authors:  Pengyu Guo; Wanhai Xu; Huibo Li; Tong Ren; Shaobin Ni; Minghua Ren
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.